Green Thumb Industries (GTBIF) Consolidated Net Income (2019 - 2026)
Green Thumb Industries (GTBIF) posted Consolidated Net Income of $15.0 million for Q1 2026, down 93.04% on a QoQ basis from $216.3 million in Q4 2025, and up 79.11% year-over-year from $8.4 million in Q1 2025.
Green Thumb Industries (GTBIF) Consolidated Net Income (2019 - 2026) Analysis & Trends
Green Thumb Industries' Consolidated Net Income history runs 8 years deep, the most recent figure standing at $15.0 million for Q1 2026.
- Quarterly Consolidated Net Income rose 79.11% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $255.8 million (up 63.51% YoY) and the FY2025 annual result came in at $249.2 million, up 38.89% from the prior year.
- Consolidated Net Income was $15.0 million for Q1 2026 at Green Thumb Industries, down from $216.3 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $216.3 million in Q4 2025 and bottomed at -$99.0 million in Q4 2022.
- A 5-year average of $31.3 million and a median of $15.0 million in 2026 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2022 — Consolidated Net Income tumbled 166.62% — and 2024, when it surged 233.31%.
- Green Thumb Industries' Consolidated Net Income stood at -$99.0 million in 2022, then soared by 190.29% to $89.4 million in 2023, then jumped by 32.44% to $118.4 million in 2024, then jumped by 82.7% to $216.3 million in 2025, then slumped by 93.04% to $15.0 million in 2026.
- Business Quant data shows GTBIF's Consolidated Net Income at $15.0 million in Q1 2026, $216.3 million in Q4 2025, and $23.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 15.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.05 Mn |
| Dec 31, 2025 | 216.27 Mn |
| Sep 30, 2025 | 23.80 Mn |
| Jun 30, 2025 | 732,000.00 |
| Mar 31, 2025 | 8.40 Mn |
| Dec 31, 2024 | 118.37 Mn |
| Sep 30, 2024 | 8.78 Mn |
| Jun 30, 2024 | 20.92 Mn |
| Mar 31, 2024 | 31.35 Mn |
| Dec 31, 2023 | 89.38 Mn |
| Sep 30, 2023 | 10.81 Mn |
| Jun 30, 2023 | 13.69 Mn |
| Mar 31, 2023 | 9.41 Mn |
| Dec 31, 2022 | -98.99 Mn |
| Sep 30, 2022 | 10.15 Mn |
| Jun 30, 2022 | 24.73 Mn |
| Mar 31, 2022 | 29.69 Mn |
| Dec 31, 2021 | 148.61 Mn |
| Sep 30, 2021 | 21.59 Mn |
| Jun 30, 2021 | 23.27 Mn |